These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22855515)

  • 1. Effects of storage on vancomycin and daptomycin MIC in susceptible blood isolates of methicillin-resistant Staphylococcus aureus.
    Ludwig F; Edwards B; Lawes T; Gould IM
    J Clin Microbiol; 2012 Oct; 50(10):3383-7. PubMed ID: 22855515
    [No Abstract]   [Full Text] [Related]  

  • 2. Precision of vancomycin and daptomycin MICs for methicillin-resistant Staphylococcus aureus and effect of subculture and storage.
    Charlton CL; Hindler JA; Turnidge J; Humphries RM
    J Clin Microbiol; 2014 Nov; 52(11):3898-905. PubMed ID: 25143569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC.
    Kao TM; Wang JT; Weng CM; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2011 Oct; 44(5):346-51. PubMed ID: 21524980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is vancomycin MIC "creep" method dependent? Analysis of methicillin-resistant Staphylococcus aureus susceptibility trends in blood isolates from North East Scotland from 2006 to 2010.
    Edwards B; Milne K; Lawes T; Cook I; Robb A; Gould IM
    J Clin Microbiol; 2012 Feb; 50(2):318-25. PubMed ID: 22135252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of vancomycin and daptomycin MIC trends for methicillin-resistant Staphylococcus aureus blood isolates over an 11 year period.
    Sancak B; Yagci S; Mirza HC; Hasçelik G
    J Antimicrob Chemother; 2013 Nov; 68(11):2689-91. PubMed ID: 23788481
    [No Abstract]   [Full Text] [Related]  

  • 6. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches.
    Holubar M; Meng L; Alegria W; Deresinski S
    Infect Dis Clin North Am; 2020 Dec; 34(4):849-861. PubMed ID: 33011050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of vancomycin and daptomycin MICs by different testing methods for methicillin-resistant Staphylococcus aureus.
    Kruzel MC; Lewis CT; Welsh KJ; Lewis EM; Dundas NE; Mohr JF; Armitige LY; Wanger A
    J Clin Microbiol; 2011 Jun; 49(6):2272-3. PubMed ID: 21450951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory and bactericidal activities of daptomycin, vancomycin, and teicoplanin against methicillin-resistant Staphylococcus aureus isolates collected from 1985 to 2007.
    Traczewski MM; Katz BD; Steenbergen JN; Brown SD
    Antimicrob Agents Chemother; 2009 May; 53(5):1735-8. PubMed ID: 19223623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study.
    Murray KP; Zhao JJ; Davis SL; Kullar R; Kaye KS; Lephart P; Rybak MJ
    Clin Infect Dis; 2013 Jun; 56(11):1562-9. PubMed ID: 23449272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus.
    Bennett JW; Murray CK; Holmes RL; Patterson JE; Jorgensen JH
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):437-40. PubMed ID: 18096352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daptomycin and vancomycin non-susceptible methicillin-resistant Staphylococcus aureus clonal lineages from bloodstream infection in a Brazilian teaching hospital.
    Damasco AP; Costa TMD; Morgado PGM; Guimarães LC; Cavalcante FS; Nouér SA; Santos KRND
    Braz J Infect Dis; 2019; 23(2):139-142. PubMed ID: 31028723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal bacteraemia caused by daptomycin-non-susceptible, vancomycin-intermediate, meticillin-resistant Staphylococcus aureus in a patient with chronic kidney disease.
    Kuo CC; Wu VC; Huang YT; Liao CH; Hsueh PR
    Int J Antimicrob Agents; 2009 Jan; 33(1):96-8. PubMed ID: 18790610
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitory activities of 11 antimicrobial agents and bactericidal activities of vancomycin and daptomycin against invasive methicillin-resistant Staphylococcus aureus isolates obtained from 1999 through 2006.
    Holmes RL; Jorgensen JH
    Antimicrob Agents Chemother; 2008 Feb; 52(2):757-60. PubMed ID: 18039923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals.
    Sader HS; Jones RN; Rossi KL; Rybak MJ
    J Antimicrob Chemother; 2009 Nov; 64(5):1024-8. PubMed ID: 19744978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of ceftobiprole, dalbavancin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus blood isolates: stratified analysis by vancomycin MIC.
    Chong YP; Park SJ; Kim HS; Kim ES; Kim MN; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Kim YS
    Diagn Microbiol Infect Dis; 2012 Jul; 73(3):264-6. PubMed ID: 22621914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bactericidal activity of ceftaroline, vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus isolates from cancer patients.
    Rolston KVI; Jamal M; Nesher L; Raad I; Rice SA; Rybak MJ; Prince RA
    J Glob Antimicrob Resist; 2019 Jun; 17():16-18. PubMed ID: 30844496
    [No Abstract]   [Full Text] [Related]  

  • 17. The Prevalence of Vancomycin-Intermediate Staphylococcus aureus and Heterogeneous VISA Among Methicillin-Resistant Strains Isolated from Pediatric Population in a Turkish University Hospital.
    Mirza HC; Sancak B; Gür D
    Microb Drug Resist; 2015 Oct; 21(5):537-44. PubMed ID: 25919019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia.
    Barber KE; Rybak MJ; Sakoulas G
    J Antimicrob Chemother; 2015 Jan; 70(1):311-3. PubMed ID: 25125677
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci].
    Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López F; Gómez M;
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):13-6. PubMed ID: 19406529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naïve patient--a review of the literature.
    van Hal SJ; Paterson DL; Gosbell IB
    Eur J Clin Microbiol Infect Dis; 2011 May; 30(5):603-10. PubMed ID: 21191627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.